ABG Management Ltd, 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 620,000 shares at $7.65 ($4.7M) on 2018-01-30, disclosed to the SEC on 2018-01-31.
Open-market sale of $4.7M SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.61 | 17,214 | $131K | 2.8% |
| 2 | $7.61 | 17,214 | $131K | 2.8% |
| 3 | $7.61 | 17,963 | $137K | 2.9% |
| 4 | $7.61 | 17,963 | $137K | 2.9% |
| 5 | $7.61 | 39,667 | $302K | 6.4% |
| 6 | $7.61 | 39,667 |
| $302K |
| 6.4% |
| 7 | $7.65 | 53,786 | $411K | 8.7% |
| 8 | $7.65 | 53,786 | $411K | 8.7% |
| 9 | $7.65 | 57,037 | $436K | 9.2% |
| 10 | $7.65 | 57,037 | $436K | 9.2% |
| 11 | $7.65 | 124,333 | $951K | 20.1% |
| 12 | $7.65 | 124,333 | $951K | 20.1% |
| Total | $7.64 avg | 620,000 | $4.7M | 100% |